Back to Resource Center

After FACTS: What’s next for HIV prevention in women?

After FACTS: What’s next for HIV prevention in women?

March 2015

Click to view Webinar

Click for full info +

After FACTS: What’s next for HIV prevention in women?

After FACTS: What's next for HIV prevention in women?
09 March 2015
click to view Webinar
In this Webinar:
Health Risk(s):

  • HIV
    • Product Type(s):

  • Vaginal Cream/Gel
    • Topic(s):

  • Product Trials

    • Full Info:


    Resource Type:

    Webinar

    Citation:

    Hosted by AVAC, this live webinar featured results from the FACTS 001 tenofovir gel study and its MPT potential, as well as discussed the open-label Partners Demonstration Project.

    Authors: AVAC.

    Health Risks(s):

    • HIV

    Product type(s):

    • VaginalCream

    Topic(s):

    • Trials

    URL of resource:

    http://www.avac.org/sites/default/files/u3/after_facts.pdf

    Back to Resource Center